Cost-effectiveness of prophylactic nasal mupirocin in patients undergoing peritoneal dialysis based on a randomized, placebo-controlled trial. [electronic resource]
Producer: 19991026Description: 105-12 p. digitalISSN:- 0305-7453
- Administration, Intranasal
- Anti-Bacterial Agents -- administration & dosage
- Belgium
- Cost-Benefit Analysis
- Female
- France
- Health Care Costs
- Humans
- Length of Stay -- economics
- Male
- Mass Screening -- economics
- Middle Aged
- Mupirocin -- administration & dosage
- Peritoneal Dialysis
- Staphylococcal Infections -- drug therapy
- Staphylococcus aureus -- drug effects
- United Kingdom
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.